HALO vs. HIMS
Compare and contrast key facts about Halozyme Therapeutics, Inc. (HALO) and Hims & Hers Health, Inc. (HIMS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HALO or HIMS.
Key characteristics
HALO | HIMS | |
---|---|---|
YTD Return | 40.07% | 158.99% |
1Y Return | 47.24% | 284.17% |
3Y Return (Ann) | 10.08% | 45.10% |
5Y Return (Ann) | 27.93% | 19.23% |
Sharpe Ratio | 1.19 | 3.70 |
Sortino Ratio | 1.82 | 3.99 |
Omega Ratio | 1.24 | 1.48 |
Calmar Ratio | 1.02 | 3.68 |
Martin Ratio | 5.17 | 15.21 |
Ulcer Index | 8.62% | 18.47% |
Daily Std Dev | 37.66% | 76.06% |
Max Drawdown | -74.26% | -87.29% |
Current Drawdown | -19.64% | -7.02% |
Fundamentals
HALO | HIMS | |
---|---|---|
Market Cap | $6.56B | $4.79B |
EPS | $2.58 | $0.08 |
PE Ratio | 20.07 | 276.88 |
Total Revenue (TTM) | $657.27M | $840.44M |
Gross Profit (TTM) | $501.51M | $645.66M |
EBITDA (TTM) | $375.07M | $22.14M |
Correlation
The correlation between HALO and HIMS is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
HALO vs. HIMS - Performance Comparison
In the year-to-date period, HALO achieves a 40.07% return, which is significantly lower than HIMS's 158.99% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HALO vs. HIMS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Halozyme Therapeutics, Inc. (HALO) and Hims & Hers Health, Inc. (HIMS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
HALO vs. HIMS - Dividend Comparison
Neither HALO nor HIMS has paid dividends to shareholders.
Drawdowns
HALO vs. HIMS - Drawdown Comparison
The maximum HALO drawdown since its inception was -74.26%, smaller than the maximum HIMS drawdown of -87.29%. Use the drawdown chart below to compare losses from any high point for HALO and HIMS. For additional features, visit the drawdowns tool.
Volatility
HALO vs. HIMS - Volatility Comparison
The current volatility for Halozyme Therapeutics, Inc. (HALO) is 14.36%, while Hims & Hers Health, Inc. (HIMS) has a volatility of 23.21%. This indicates that HALO experiences smaller price fluctuations and is considered to be less risky than HIMS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
HALO vs. HIMS - Financials Comparison
This section allows you to compare key financial metrics between Halozyme Therapeutics, Inc. and Hims & Hers Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities